Patients’ perspectives on a drug safety monitoring system for immune-mediated inflammatory diseases based on patient-reported outcomes-Reference-Cited by-同舟云学术

Patients’ perspectives on a drug safety monitoring system for immune-mediated inflammatory diseases based on patient-reported outcomes

Published:2021-08-12 Issue:12 Volume:20 Page:1565-1572
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Kosse Leanne J¹,Weits Gerda¹,Vonkeman Harald E²³^ORCID,Tas Sander W⁴,Hoentjen Frank⁵,Van Doorn Martijn BA⁶^ORCID,Spuls Phyllis I⁷,D’Haens Geert R⁸^ORCID,Nurmohamed Michael T⁹^ORCID,van Puijenbroek Eugène P¹¹⁰^ORCID,Van Den Bemt Bart JF¹¹¹²,Jessurun Naomi T¹^ORCID

Affiliation:

1. Netherlands Pharmacovigilance Centre Lareb, ‘s-hertogenbosch, The Netherlands

2. Department of Rheumatology, Medisch Spectrum Twente, Enschede, The Netherlands

3. Department of Psychology, Health & Technology, University of Twente, Enschede, The Netherlands

4. Department of Rheumatology & Clinical Immunology, Amsterdam UMC, Location Academic Medical Center, University of Amsterdam, Amsterdam Infection & Immunity Institute and Amsterdam Rheumatology & Immunology Center (ARC), Amsterdam, The Netherlands

5. Department of Gastroenterology, Radboudumc, Nijmegen, The Netherlands

6. Department of Dermatology, Erasmus MC, Rotterdam, The Netherlands

7. Department of Dermatology, Amsterdam UMC, Amsterdam Public Health, Immunity and Infections, University of Amsterdam, Amsterdam, The Netherlands

8. Department of Gastroenterology, Amsterdam UMC, Location Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands

9. Department of Rheumatology, Reade and Amsterdam Rheumatology & Immunology Center (ARC), Amsterdam, The Netherlands

10. University of Groningen, Groningen Research Institute of Pharmacy, PharmacoTherapy, Epidemiology & Pharmacoeconomics, Groningen, The Netherlands

11. Department of Pharmacy, Sint Maartenskliniek, Nijmegen, The Netherlands

12. Department of Pharmacy, Radboudumc, Nijmegen, The Netherlands

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14740338.2021.1963436

Reference36 articles.

1. History of Pharmacovigilance

2. Patient reporting of suspected adverse drug reactions: a review of published literature and international experience

3. Regulation (EU) No 1235/2010 of the European Parliament and of the Council of 15 December 2010 amending, as regards pharmacovigilance of medicinal products for human use, Regulation (EC) No 726/2004 laying down Community procedures for the authorisation a. OJ L348/1 2012.

4. Experiences with Adverse Drug Reaction Reporting by Patients

5. Patient-reported outcomes: A new era in clinical research